BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805-75. [PMID: 10605627 DOI: 10.1210/edrv.20.6.0383] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Lee JK, Jang JH, Lee JT, Lee JS. Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus. Mycobiology 2010;38:52-7. [PMID: 23956625 DOI: 10.4489/MYCO.2010.38.1.052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
2 Weng CS, Hung YL, Shyu LY, Chang YH. A study of electrical conductance of meridian in the obese during weight reduction. Am J Chin Med 2004;32:417-25. [PMID: 15344425 DOI: 10.1142/S0192415X04002077] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
3 Baptista T, ElFakih Y, Uzcátegui E, Sandia I, Tálamo E, Araujo de Baptista E, Beaulieu S. Pharmacological management of atypical antipsychotic-induced weight gain. CNS Drugs 2008;22:477-95. [PMID: 18484791 DOI: 10.2165/00023210-200822060-00003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 5.6] [Reference Citation Analysis]
4 Del Parigi A, Chen K, Gautier J, Salbe AD, Pratley RE, Ravussin E, Reiman EM, Tataranni PA. Sex differences in the human brain's response to hunger and satiation. The American Journal of Clinical Nutrition 2002;75:1017-22. [DOI: 10.1093/ajcn/75.6.1017] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 4.6] [Reference Citation Analysis]
5 Thouri A, Chahdoura H, El Arem A, Omri Hichri A, Ben Hassin R, Achour L. Effect of solvents extraction on phytochemical components and biological activities of Tunisian date seeds (var. Korkobbi and Arechti). BMC Complement Altern Med 2017;17:248. [PMID: 28472941 DOI: 10.1186/s12906-017-1751-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 7.4] [Reference Citation Analysis]
6 Sangwai M, Sardar S, Vavia P. Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition. Pharm Dev Technol 2014;19:31-41. [PMID: 23259606 DOI: 10.3109/10837450.2012.751404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
7 Aryana K, Greenway F, Dhurandhar N, Tulley R, Finley J, Keenan M, Martin R, Pelkman C, Olson D, Zheng J. A resistant-starch enriched yogurt: fermentability, sensory characteristics, and a pilot study in children. F1000Res 2015;4:139. [PMID: 26925221 DOI: 10.12688/f1000research.6451.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Mizuno CS, Chittiboyina AG, Patny A, Kurtz TW, Pershadsingh HA, Speth RC, Karamyan VT, Avery MA. Design, synthesis, and docking studies of telmisartan analogs for the treatment of metabolic syndrome. Med Chem Res 2009;18:611-28. [DOI: 10.1007/s00044-008-9153-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
9 Sompong W, Muangngam N, Kongpatpharnich A, Manacharoenlarp C, Amorworasin C, Suantawee T, Thilavech T, Adisakwattana S. The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion. BMC Complement Altern Med 2016;16:439. [PMID: 27814716 DOI: 10.1186/s12906-016-1424-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
10 Seagle HM, Wyatt H, Hill JO. Obesity: Overview of Treatments and Interventions. Nutrition in the Prevention and Treatment of Disease. Elsevier; 2001. pp. 465-80. [DOI: 10.1016/b978-012193155-1/50033-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
11 Sari R, Balci MK, Coban E, Yazicioglu G. Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women. Int J Obes Relat Metab Disord 2004;28:1059-63. [PMID: 15211369 DOI: 10.1038/sj.ijo.0802707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
12 Foster-Schubert KE, Cummings DE. Emerging therapeutic strategies for obesity. Endocr Rev 2006;27:779-93. [PMID: 17122357 DOI: 10.1210/er.2006-0041] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
13 Frank A. The long-term management of obesity with continuing pharmacotherapy. Obes Res 2004;12:1821-7. [PMID: 15601978 DOI: 10.1038/oby.2004.226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
14 Kim KK, Suh HS, Hwang IC, Ko KD. Influence of eating behaviors on short-term weight loss by orlistat and anorectic agent. Eat Behav 2014;15:87-90. [PMID: 24411757 DOI: 10.1016/j.eatbeh.2013.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Ghanemi A, Yoshioka M, St-Amand J. Trefoil Factor Family Member 2: From a High-Fat-Induced Gene to a Potential Obesity Therapy Target. Metabolites 2021;11:536. [PMID: 34436477 DOI: 10.3390/metabo11080536] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Krysiak R, Okopie? B, Belowski D, Madej A, Herman ZS. Recent insights into body weight control: From physiology to pathology. J Peptide Sci 2001;7:571-8. [DOI: 10.1002/psc.354] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
17 Bray GA. Is new hope on the horizon for obesity? Lancet. 2008;372:1859-1860. [PMID: 19041787 DOI: 10.1016/s0140-6736(08)61792-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Araújo JR, Martel F. Sibutramine effects on central mechanisms regulating energy homeostasis. Curr Neuropharmacol 2012;10:49-52. [PMID: 22942877 DOI: 10.2174/157015912799362788] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
19 Shukla S, Park J, Kim D, Hong S, Lee JS, Kim M. Total phenolic content, antioxidant, tyrosinase and α-glucosidase inhibitory activities of water soluble extracts of noble starter culture Doenjang, a Korean fermented soybean sauce variety. Food Control 2016;59:854-61. [DOI: 10.1016/j.foodcont.2015.07.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
20 Pagotto U, Pasquali R. Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. Lancet. 2005;365:1363-1364. [PMID: 15836868 DOI: 10.1016/s0140-6736(05)66348-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
21 Lee JK, Song JH, Lee JS. Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts. Mycobiology 2010;38:58-61. [PMID: 23956626 DOI: 10.4489/MYCO.2010.38.1.058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Obes Metab 2002;4:49-55. [PMID: 11874442 DOI: 10.1046/j.1463-1326.2002.00181.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
23 Gonçalves CL, Scaini G, Rezin GT, Jeremias IC, Bez GD, Daufenbach JF, Gomes LM, Ferreira GK, Zugno AI, Streck EL. Effects of acute administration of mazindol on brain energy metabolism in adult mice. Acta Neuropsychiatr 2014;26:146-54. [PMID: 25142190 DOI: 10.1017/neu.2013.43] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Lindblom J, Kask A, Hägg E, Härmark L, Bergström L, Wikberg J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 2002;45:119-24. [PMID: 11846623 DOI: 10.1006/phrs.2001.0913] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
25 Doulberis M, Papaefthymiou A, Polyzos SA, Katsinelos P, Grigoriadis N, Srivastava DS, Kountouras J. Rodent models of obesity. Minerva Endocrinol 2020;45:243-63. [PMID: 31738033 DOI: 10.23736/S0391-1977.19.03058-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Phelan S, Wadden TA. Combining Behavioral and Pharmacological Treatments for Obesity. Obesity Research 2002;10:560-74. [DOI: 10.1038/oby.2002.77] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
27 Bickel M, Gossel M, Geisen K, Jaehne G, Lang HJ, Rosenburg R, Sandow J. Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats. Int J Obes 2004;28:211-21. [DOI: 10.1038/sj.ijo.0802540] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
28 Korner J, Eberle MA. An update on the science and therapy of obesity and its relationship to osteoarthritis. Curr Rheumatol Rep 2001;3:101-6. [DOI: 10.1007/s11926-001-0004-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
29 Koncz D, Tóth B, Roza O, Csupor D. A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss. Front Pharmacol 2020;11:611361. [PMID: 33574758 DOI: 10.3389/fphar.2020.611361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
30 Li S, Maude-Griffin R, Sun Y, Starkebaum W, Chen JD. Food intake and body weight responses to intermittent vs. continuous gastric electrical stimulation in diet-induced obese rats. Obes Surg. 2013;23:71-79. [PMID: 23001597 DOI: 10.1007/s11695-012-0773-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
31 Hamilton M. Strategies for the Management of Patients with Obesity: . Treatments in Endocrinology 2002;1:21-36. [DOI: 10.2165/00024677-200201010-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 Allison DB, Gadbury G, Schwartz LG, Murugesan R, Kraker JL, Heshka S, Fontaine KR, Heymsfield SB. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr 2003;57:514-22. [DOI: 10.1038/sj.ejcn.1601587] [Cited by in Crossref: 111] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
33 Twiner EM, Liu Z, Gimble J, Yu Y, Greenway F. Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix. Adv Ther 2011;28:857-65. [PMID: 21975926 DOI: 10.1007/s12325-011-0061-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Volek JS, Vanheest JL, Forsythe CE. Diet and exercise for weight loss: a review of current issues. Sports Med 2005;35:1-9. [PMID: 15651909 DOI: 10.2165/00007256-200535010-00001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
35 Wilborn C, Beckham J, Campbell B, Harvey T, Galbreath M, La Bounty P, Nassar E, Wismann J, Kreider R. Obesity: prevalence, theories, medical consequences, management, and research directions. J Int Soc Sports Nutr 2005;2:4-31. [PMID: 18500955 DOI: 10.1186/1550-2783-2-2-4] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 5.7] [Reference Citation Analysis]
36 Liu CP, Chau PC, Chang CT, An LM, Yeh JL, Chen IJ, Wu BN. KMUP-1, a GPCR Modulator, Attenuates Triglyceride Accumulation Involved MAPKs/Akt/PPARγ and PKA/PKG/HSL Signaling in 3T3-L1 Preadipocytes. Molecules 2018;23:E2433. [PMID: 30249030 DOI: 10.3390/molecules23102433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Park CH, Jeong SJ, Lee HJ, Lee EO, Bae H, Lee MH, Kim SH, Jung HJ, Ahn KS, Kim SH. Traditional medicine Taeeumjowitangkagambang exerts antiobesity and hypolipidemic effects via antioxidant enzyme enhancement. Phytother Res 2010;24:1700-9. [PMID: 21031632 DOI: 10.1002/ptr.3179] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
38 Hu D, Xie J, Fu P, Zhou J, Yu D, Whelton PK, He J, Gu D. Central rather than overall obesity is related to diabetes in the Chinese population: the InterASIA study. Obesity (Silver Spring). 2007;15:2809-2816. [PMID: 18070772 DOI: 10.1038/oby.2007.333] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
39 Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. Int J Obes (Lond) 2006;30:331-41. [PMID: 16158082 DOI: 10.1038/sj.ijo.0803074] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
40 Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr 2002;132:3451S-5S. [PMID: 12421869 DOI: 10.1093/jn/132.11.3451S] [Cited by in Crossref: 119] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
41 Parra MC, Loftus RW. Obesity and Regional Anesthesia. International Anesthesiology Clinics 2013;51:90-112. [DOI: 10.1097/aia.0b013e31829b8f4b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
42 Klaus S, Seivert A, Boeuf S. Effect of the β3-adrenergic agonist Cl316,243 on functional differentiation of white and brown adipocytes in primary cell culture. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2001;1539:85-92. [DOI: 10.1016/s0167-4889(01)00093-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
43 Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P; Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric 2012;15:419-29. [PMID: 22978257 DOI: 10.3109/13697137.2012.707385] [Cited by in Crossref: 249] [Cited by in F6Publishing: 213] [Article Influence: 27.7] [Reference Citation Analysis]
44 Bray GA, Ryan DH, Harsha DW. Diet, weight loss, and cardiovascular disease prevention. Curr Treat Options Cardio Med 2003;5:259-69. [DOI: 10.1007/s11936-003-0025-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
45 Bray GA. Drug Insight: appetite suppressants. Nat Rev Gastroenterol Hepatol 2005;2:89-95. [DOI: 10.1038/ncpgasthep0092] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
46 Valentino MA, Colon-Gonzalez F, Lin JE, Waldman SA. Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity. Expert Rev Endocrinol Metab 2010;5:765-83. [PMID: 21297878 DOI: 10.1586/eem.10.33] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
47 Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002;123:882-932. [DOI: 10.1053/gast.2002.35514] [Cited by in Crossref: 164] [Cited by in F6Publishing: 127] [Article Influence: 8.2] [Reference Citation Analysis]
48 Cepoi D, Phillips T, Cismowski M, Goodfellow VS, Ling N, Cone RD, Fan W. Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Research 2004;1000:64-71. [DOI: 10.1016/j.brainres.2003.10.041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
49 Moyers SB. Medications as Adjunct Therapy for Weight Loss: Approved and Off-Label Agents in Use. Journal of the American Dietetic Association 2005;105:948-59. [DOI: 10.1016/j.jada.2005.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
50 Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab 2006;2:447-58. [PMID: 16932334 DOI: 10.1038/ncpendmet0220] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 5.9] [Reference Citation Analysis]
51 Ouyang H, Chen JDZ. Long-pulse gastric electrical stimulation at tachygastrial frequency reduces food intake by inhibiting proximal gastric tone. Scandinavian Journal of Gastroenterology 2009;42:702-7. [DOI: 10.1080/00365520601076140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
52 Lucas KH, Kaplan-machlis B. Orlistat — A Novel Weight Loss Therapy. Ann Pharmacother 2001;35:314-28. [DOI: 10.1345/aph.19412] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
53 Tucci SA, Boyland EJ, Halford JC. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents. Diabetes Metab Syndr Obes 2010;3:125-43. [PMID: 21437083 DOI: 10.2147/dmsott.s7005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
54 Jakicic (CHAIR) JM, Clark K, Coleman E, Donnelly JE, Foreyt J, Melanson E, Volek J, Volpe SL. Appropriate Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults: . Medicine & Science in Sports & Exercise 2001;33:2145-56. [DOI: 10.1097/00005768-200112000-00026] [Cited by in Crossref: 429] [Cited by in F6Publishing: 348] [Article Influence: 20.4] [Reference Citation Analysis]
55 DeWald T, Khaodhiar L, Donahue MP, Blackburn G. Pharmacological and surgical treatments for obesity. Am Heart J 2006;151:604-24. [PMID: 16504622 DOI: 10.1016/j.ahj.2005.03.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
56 Jung EY, Suh HJ, Kim SY, Hong YS, Kim MJ, Chang UJ. Appetite suppressive effects of yeast hydrolysate on nitric oxide synthase (NOS) expression and vasoactive intestinal peptide (VIP) immunoreactivity in hypothalamus. Phytother Res 2008;22:1417-22. [DOI: 10.1002/ptr.2264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
57 He R, Chen L, Lin B, Matsui Y, Yao X, Kurihara H. Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects. Chin J Integr Med 2009;15:34-41. [DOI: 10.1007/s11655-009-0034-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
58 Margareto J, Larrarte E, Marti A, Martinez JA. Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta3-adrenergic agonist. Biochem Pharmacol 2001;61:1471-8. [PMID: 11377376 DOI: 10.1016/s0006-2952(01)00562-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
59 Poston WSC, Foreyt JP. Sibutramine and the management of obesity. Expert Opinion on Pharmacotherapy 2005;5:633-42. [DOI: 10.1517/14656566.5.3.633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
60 Poston WSC, Haddock CK, Dill PL, Thayer B, Foreyt JP. Lifestyle Treatments in Randomized Clinical Trials of Pharmacotherapies for Obesity. Obesity Research 2001;9:552-63. [DOI: 10.1038/oby.2001.72] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
61 Carpino PA. Patent focus on new anti-obesity agents: September 1999 - February 2000. Expert Opinion on Therapeutic Patents 2005;10:819-31. [DOI: 10.1517/13543776.10.6.819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
62 Anderson JW, Luan J, Høie LH. Structured weight-loss programs: meta-analysis of weight loss at 24 weeks and assessment of effects of intervention intensity. Adv Ther 2004;21:61-75. [PMID: 15310080 DOI: 10.1007/BF02850334] [Cited by in Crossref: 51] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
63 Teodoro JS, Varela AT, Rolo AP, Palmeira CM. High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes. Genes Nutr 2014;9:406. [PMID: 24842072 DOI: 10.1007/s12263-014-0406-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
64 Shettar V, Patel S, Kidambi S. Epidemiology of Obesity and Pharmacologic Treatment Options. Nutr Clin Pract 2017;32:441-62. [DOI: 10.1177/0884533617713189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
65 Bray GA. Drug treatment of obesity. Rev Endocr Metab Disord 2001;2:403-18. [PMID: 11725727 DOI: 10.1023/a:1011808701117] [Cited by in Crossref: 56] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
66 Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW. Anesthetic considerations for bariatric surgery. Anesth Analg 2002;95:1793-805. [PMID: 12456461 DOI: 10.1097/00000539-200212000-00061] [Cited by in Crossref: 185] [Cited by in F6Publishing: 129] [Article Influence: 9.7] [Reference Citation Analysis]
67 Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;:CD004096. [PMID: 15674929 DOI: 10.1002/14651858.CD004096.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
68 Bray GA, Tartaglia LA. Medicinal strategies in the treatment of obesity. Nature 2000;404:672-7. [DOI: 10.1038/35007544] [Cited by in Crossref: 297] [Cited by in F6Publishing: 228] [Article Influence: 13.5] [Reference Citation Analysis]
69 Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes 2004;28:34-8. [DOI: 10.1038/sj.ijo.0802479] [Cited by in Crossref: 83] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
70 Adhikari S, Bhattarai K, Abe Y, Kira M, Fujitani M, Miyada T, Kishida T. Dietary daidzein decreases food intake accompanied with delayed gastric emptying in ovariectomized rats. Biosci Biotechnol Biochem 2020;84:1232-8. [PMID: 32067573 DOI: 10.1080/09168451.2020.1723404] [Reference Citation Analysis]
71 Aryana K, Greenway F, Dhurandhar N, Tulley R, Finley J, Keenan M, Martin R, Pelkman C, Olson D, Zheng J. A resistant-starch enriched yogurt: fermentability, sensory characteristics, and a pilot study in children. F1000Res 2015;4:139. [PMID: 26925221 DOI: 10.12688/f1000research.6451.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
72 Olsen TG, Barnes AA, King JA. Elevated hCG Outside of Pregnancy—Diagnostic Considerations and Laboratory Evaluation. Obstetrical & Gynecological Survey 2007;62:669-74. [DOI: 10.1097/01.ogx.0000281556.13788.61] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
73 Hendricks EJ, Greenway FL. A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program. American Journal of Therapeutics 2011;18:292-9. [DOI: 10.1097/mjt.0b013e3181d070d7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
74 Acharya NV, Wilton LV, Shakir SAW. Safety profile of orlistat: results of a prescription-event monitoring study. Int J Obes 2006;30:1645-52. [DOI: 10.1038/sj.ijo.0803323] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
75 Yoon S, Rhee Y, Lee H, Lee E, Lee M, Ahn K, Lim H, Kim S. Uncoupled protein 3 and p38 signal pathways are involved in anti-obesity activity of Solanum tuberosum L. cv. Bora Valley. Journal of Ethnopharmacology 2008;118:396-404. [DOI: 10.1016/j.jep.2008.05.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
76 . Position of the American Dietetic Association: Integration of medical nutrition therapy and pharmacotherapy. Journal of the American Dietetic Association 2003;103:1363-70. [DOI: 10.1016/j.jada.2003.08.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
77 Hunter RJ, Navo MA, Thaker PH, Bodurka DC, Wolf JK, Smith JA. Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA). Cancer Treatment Reviews 2009;35:69-78. [DOI: 10.1016/j.ctrv.2008.07.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
78 Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E; Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007;176:S1-13. [PMID: 17420481 DOI: 10.1503/cmaj.061409] [Cited by in Crossref: 569] [Cited by in F6Publishing: 512] [Article Influence: 37.9] [Reference Citation Analysis]
79 Weiss R. Devices for the treatment of obesity: will understanding the physiology of satiety unravel new targets for intervention? J Diabetes Sci Technol 2008;2:501-8. [PMID: 19885218 DOI: 10.1177/193229680800200323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
80 Fuchs T, Loureiro MDP, Macedo LE, Nocca D, Nedelcu M, Costa-casagrande TA. Modelos animais na síndrome metabólica. Rev Col Bras Cir 2018;45. [DOI: 10.1590/0100-6991e-20181975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
81 Inui A. Transgenic study of energy homeostasis equation: implications and confounding influences. FASEB j 2000;14:2158-70. [DOI: 10.1096/fj.00-0291rev] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
82 Tsai C, Chiu W, Yang N, Ouyang C, Yen Y. A novel green tea meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. International Journal of Food Sciences and Nutrition 2009;60:151-9. [DOI: 10.1080/09637480903136667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
83 Rahim F, Ullah K, Ullah H, Wadood A, Taha M, Rehman AU, uddin I, Ashraf M, Shaukat A, Rehman W, Hussain S, Khan KM. Triazinoindole analogs as potent inhibitors of α-glucosidase: Synthesis, biological evaluation and molecular docking studies. Bioorganic Chemistry 2015;58:81-7. [DOI: 10.1016/j.bioorg.2014.12.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 10.4] [Reference Citation Analysis]
84 Sherafat-Kazemzadeh R, Yanovski SZ, Yanovski JA. Pharmacotherapy for childhood obesity: present and future prospects. Int J Obes (Lond) 2013;37:1-15. [PMID: 22929210 DOI: 10.1038/ijo.2012.144] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
85 Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722-33. [PMID: 12805393 DOI: 10.1038/oby.2003.102] [Cited by in Crossref: 244] [Cited by in F6Publishing: 197] [Article Influence: 13.6] [Reference Citation Analysis]
86 Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring) 2009;17:1730-5. [PMID: 19300434 DOI: 10.1038/oby.2009.69] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
87 Ouyang H, Yin J, Chen JD. Therapeutic potential of gastric electrical stimulation for obesity and its possible mechanisms: a preliminary canine study. Dig Dis Sci. 2003;48:698-705. [PMID: 12741458 DOI: 10.1023/a:1022824406648] [Cited by in Crossref: 50] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
88 Hiatt WR, Thomas A, Goldfine AB. What cost weight loss? Circulation 2012;125:1171-7. [PMID: 22392864 DOI: 10.1161/CIRCULATIONAHA.111.023499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
89 Taylor VH, Stonehocker B, Steele M, Sharma AM. An overview of treatments for obesity in a population with mental illness. Can J Psychiatry 2012;57:13-20. [PMID: 22296963 DOI: 10.1177/070674371205700104] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ye Z, Chen L, Yang Z, Li Q, Huang Y, He M, Zhang S, Zhang Z, Wang X, Zhao W, Hu J, Liu C, Qu S, Hu R. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One 2011;6:e21551. [PMID: 21829436 DOI: 10.1371/journal.pone.0021551] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
91 Song G, Hou X, Sun Y, Yang B, Qian W, Chen JD. Effects of retrograde gastric electrical stimulation with pulse trains on gastric emptying of solids and plasma hormones in dogs. The American Journal of Surgery 2007;194:122-7. [DOI: 10.1016/j.amjsurg.2006.12.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
92 Cavaliere H, Floriano I, Medeiros-Neto G. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes Relat Metab Disord 2001;25:1095-9. [PMID: 11443512 DOI: 10.1038/sj.ijo.0801645] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
93 Lev-ran A. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 2001;17:347-62. [DOI: 10.1002/dmrr.230] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 4.0] [Reference Citation Analysis]
94 Sellayah D, Sikder D. Food for Thought: Understanding the Multifaceted Nature of Orexins. Endocrinology 2013;154:3990-9. [DOI: 10.1210/en.2013-1488] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
95 Liu J, Zhao Y, Huang C, Li Y, Guo F. Prenylated flavonoid‐standardized extract from seeds of Psoralea corylifolia L. activated fat browning in high‐fat diet–induced obese mice. Phytotherapy Research 2019;33:1851-64. [DOI: 10.1002/ptr.6374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Chugh PK, Sharma S. Recent advances in the pathophysiology and pharmacological treatment of obesity: Recent advances in obesity. Journal of Clinical Pharmacy and Therapeutics 2012;37:525-35. [DOI: 10.1111/j.1365-2710.2012.01347.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
97 Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG; American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004;80:257-263. [PMID: 15277143 DOI: 10.1093/ajcn/80.2.257] [Cited by in Crossref: 125] [Cited by in F6Publishing: 112] [Article Influence: 6.9] [Reference Citation Analysis]
98 Anderson JW, Greenway FL, Fujioka K, Gadde KM, Mckenney J, O'neil PM. Bupropion SR Enhances Weight Loss: A 48-Week Double-Blind, Placebo- Controlled Trial. Obesity Research 2002;10:633-41. [DOI: 10.1038/oby.2002.86] [Cited by in Crossref: 210] [Cited by in F6Publishing: 165] [Article Influence: 21.0] [Reference Citation Analysis]
99 Bray GA, Champagne CM. Beyond Energy Balance: There Is More to Obesity than Kilocalories. Journal of the American Dietetic Association 2005;105:17-23. [DOI: 10.1016/j.jada.2005.02.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
100 Li Z, Hong K, Yip I, Huerta S, Bowerman S, Walker J, Wang H, Elashoff R, Go VL, Heber D. Body weight loss with phentermine alone versus phentermine and fenfluramine with very-low-calorie diet in an outpatient obesity management program: a retrospective study. Curr Ther Res Clin Exp 2003;64:447-60. [PMID: 24944395 DOI: 10.1016/S0011-393X(03)00126-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
101 Hauner H, Meier M, J??ckel K, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein ??3 subunit gene (GNB3) C825T polymorphism: . Pharmacogenetics 2003;13:453-9. [DOI: 10.1097/00008571-200308000-00003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 3.7] [Reference Citation Analysis]
102 Brunton PA, Ratnayake J, Bodansky HJ, Mei L, Veerasamy A, Hall R. An intraoral device for weight loss: initial clinical findings. Br Dent J 2021. [PMID: 34172922 DOI: 10.1038/s41415-021-3081-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women. Endocr Res 2004;30:159-67. [PMID: 15473126 DOI: 10.1081/erc-200027356] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
104 Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007;66:433-439. [PMID: 17204567 DOI: 10.1136/ard.2006.065904] [Cited by in Crossref: 377] [Cited by in F6Publishing: 297] [Article Influence: 25.1] [Reference Citation Analysis]
105 Rissanen A, Lean M, Rössner S, Segal KR, Sjöström L. Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord 2003;27:103-9. [PMID: 12532161 DOI: 10.1038/sj.ijo.0802165] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
106 Si Y, Yoon J, Lee K. Flux profile and modularity analysis of time-dependent metabolic changes of de novo adipocyte formation. Am J Physiol Endocrinol Metab 2007;292:E1637-46. [PMID: 17284573 DOI: 10.1152/ajpendo.00670.2006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
107 Nilsson C, Raun K, Yan FF, Larsen MO, Tang-Christensen M. Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin 2012;33:173-81. [PMID: 22301857 DOI: 10.1038/aps.2011.203] [Cited by in Crossref: 161] [Cited by in F6Publishing: 82] [Article Influence: 16.1] [Reference Citation Analysis]
108 Mancini MC, Halpern A. Tratamento Farmacológico da Obesidade. Arq Bras Endocrinol Metab 2002;46:497-512. [DOI: 10.1590/s0004-27302002000500003] [Cited by in Crossref: 16] [Article Influence: 0.8] [Reference Citation Analysis]
109 Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiy S, Brookes PS, Niijima A, Inui A, Meguid MM. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2007;293:R1474-89. [DOI: 10.1152/ajpregu.00171.2007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
110 Yin J, Chen JD. Mechanisms and potential applications of intestinal electrical stimulation. Dig Dis Sci. 2010;55:1208-1220. [PMID: 19629689 DOI: 10.1007/s10620-009-0884-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
111 Yin J, Zhang J, Chen JD. Inhibitory effects of intestinal electrical stimulation on food intake, weight loss and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R78-82. [PMID: 17363682 DOI: 10.1152/ajpregu.00318.2006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
112 Kim Y, Oh Y, Yoo S, Park K, Kang W, Park S. Antiobesity effect of recombinant human caseinomacropeptide in Sprague-Dawley rat. Biotechnol Bioprocess Eng 2005;10:242-7. [DOI: 10.1007/bf02932020] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
113 Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial. Obes Res 2000;8:431-7. [PMID: 11011909 DOI: 10.1038/oby.2000.53] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 4.0] [Reference Citation Analysis]